Findings

What do systematic reviews say?

9 questions · 9 findings · 7 reviews · Hepato-Biliary

Sort:Best matchNewest Highest certainty Download CSV

No studies found 6 · 66.7%GRADE not reported 1 · 11.1%Very low 1 · 11.1%Low 0 · 0%Moderate 1 · 11.1%High 0 · 0%

Radix Sophorae flavescentis vs placebo or no intervention

Health‐related quality of life · chronic hepatitis B

The review found no eligible studies for this question.

1 finding from 1 review

Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prostaglandin vs placebo or usual care

Health‐related quality of life · adult patients after liver transplantation.

The review found no eligible studies for this question.

1 finding from 1 review

Prostaglandins for adult liver transplanted recipients 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Vitamin D vs placebo or no intervention

Health‐related quality of life · people with chronic liver diseases

1 finding from 1 review

Vitamin D supplementation for chronic liver diseases in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Phamacotherapies that specifically target ammonia vs placebo or non‐absorbable disaccharides

Health‐related quality of life · adults with cirrhosis and hepatic encephalopathy

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in… 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ursodeoxycholic acid vs placebo

Health‐related quality of life · people with primary sclerosing cholangitis

1 finding from 1 review

Pharmacological interventions for primary sclerosing cholangitis 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 198 participants
Very low

Transarterial embolisation vs no intervention

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transarterial chemoembolisation vs no intervention

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transarterial embolisation and transarterial chemoembolisation vs no intervention

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Rifaximin vs placebo or no intervention

Health‐related quality of life ‐ all trials Higher scores indicate improved health‐related quality of life · prevention and treatment of hepatic encephalopathy in people with cirrhosis

1 finding from 1 review

Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 214 participants
Moderate